Annual EBITDA
-$210.84 M
+$126.17 M+37.44%
December 31, 2023
Summary
- As of February 7, 2025, CLOV annual EBITDA is -$210.84 million, with the most recent change of +$126.17 million (+37.44%) on December 31, 2023.
- During the last 3 years, CLOV annual EBITDA has fallen by -$132.12 million (-167.81%).
- CLOV annual EBITDA is now -167.81% below its all-time high of -$78.73 million, reached on December 31, 2020.
Performance
CLOV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$8.45 M
-$15.95 M-212.61%
September 30, 2024
Summary
- As of February 7, 2025, CLOV quarterly EBITDA is -$8.45 million, with the most recent change of -$15.95 million (-212.61%) on September 30, 2024.
- Over the past year, CLOV quarterly EBITDA has increased by +$13.59 million (+61.66%).
- CLOV quarterly EBITDA is now -131.79% below its all-time high of $26.57 million, reached on September 30, 2020.
Performance
CLOV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$92.78 M
+$32.47 M+25.92%
September 30, 2024
Summary
- As of February 7, 2025, CLOV TTM EBITDA is -$92.78 million, with the most recent change of +$32.47 million (+25.92%) on September 30, 2024.
- Over the past year, CLOV TTM EBITDA has increased by +$67.85 million (+42.24%).
- CLOV TTM EBITDA is now -400.35% below its all-time high of $30.89 million, reached on September 30, 2020.
Performance
CLOV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CLOV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.4% | +61.7% | +42.2% |
| 3 y3 years | -167.8% | +90.1% | +72.5% |
| 5 y5 years | +35.0% | +90.1% | +72.5% |
CLOV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.0% | -212.6% | +95.5% | at high | +84.8% |
| 5 y | 5-year | -167.8% | +63.0% | -131.8% | +97.3% | -400.4% | +84.8% |
| alltime | all time | -167.8% | +63.0% | -131.8% | +97.3% | -400.4% | +84.8% |
Clover Health Investments EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.45 M(-212.6%) | -$92.78 M(-25.9%) |
| Jun 2024 | - | $7.50 M(-134.0%) | -$125.24 M(-22.0%) |
| Mar 2024 | - | -$22.03 M(-68.4%) | -$160.63 M(-25.7%) |
| Dec 2023 | -$210.84 M(-37.4%) | -$69.80 M(+70.6%) | -$216.21 M(-6.5%) |
| Sep 2023 | - | -$40.91 M(+46.7%) | -$231.34 M(-12.7%) |
| Jun 2023 | - | -$27.88 M(-64.1%) | -$264.88 M(-22.2%) |
| Mar 2023 | - | -$77.61 M(-8.6%) | -$340.37 M(+1.0%) |
| Dec 2022 | -$337.02 M | -$84.93 M(+14.1%) | -$337.02 M(-23.1%) |
| Sep 2022 | - | -$74.46 M(-28.0%) | -$438.03 M(+10.2%) |
| Jun 2022 | - | -$103.37 M(+39.2%) | -$397.55 M(-34.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$74.26 M(-60.1%) | -$610.44 M(+7.2%) |
| Dec 2021 | -$569.60 M(+623.5%) | -$185.94 M(+447.2%) | -$569.60 M(+15.5%) |
| Sep 2021 | - | -$33.98 M(-89.3%) | -$493.30 M(+14.0%) |
| Jun 2021 | - | -$316.26 M(+846.3%) | -$432.74 M(+343.2%) |
| Mar 2021 | - | -$33.42 M(-69.5%) | -$97.64 M(+24.0%) |
| Dec 2020 | -$78.73 M(-75.7%) | -$109.64 M(-512.6%) | -$78.73 M(-354.9%) |
| Sep 2020 | - | $26.57 M(+41.0%) | $30.89 M(+615.5%) |
| Jun 2020 | - | $18.85 M(-229.9%) | $4.32 M(-129.7%) |
| Mar 2020 | - | -$14.51 M(>+9900.0%) | -$14.53 M(>+9900.0%) |
| Dec 2019 | -$324.12 M | -$17.60 K | -$17.60 K |
FAQ
- What is Clover Health Investments annual EBITDA?
- What is the all time high annual EBITDA for Clover Health Investments?
- What is Clover Health Investments annual EBITDA year-on-year change?
- What is Clover Health Investments quarterly EBITDA?
- What is the all time high quarterly EBITDA for Clover Health Investments?
- What is Clover Health Investments quarterly EBITDA year-on-year change?
- What is Clover Health Investments TTM EBITDA?
- What is the all time high TTM EBITDA for Clover Health Investments?
- What is Clover Health Investments TTM EBITDA year-on-year change?
What is Clover Health Investments annual EBITDA?
The current annual EBITDA of CLOV is -$210.84 M
What is the all time high annual EBITDA for Clover Health Investments?
Clover Health Investments all-time high annual EBITDA is -$78.73 M
What is Clover Health Investments annual EBITDA year-on-year change?
Over the past year, CLOV annual EBITDA has changed by +$126.17 M (+37.44%)
What is Clover Health Investments quarterly EBITDA?
The current quarterly EBITDA of CLOV is -$8.45 M
What is the all time high quarterly EBITDA for Clover Health Investments?
Clover Health Investments all-time high quarterly EBITDA is $26.57 M
What is Clover Health Investments quarterly EBITDA year-on-year change?
Over the past year, CLOV quarterly EBITDA has changed by +$13.59 M (+61.66%)
What is Clover Health Investments TTM EBITDA?
The current TTM EBITDA of CLOV is -$92.78 M
What is the all time high TTM EBITDA for Clover Health Investments?
Clover Health Investments all-time high TTM EBITDA is $30.89 M
What is Clover Health Investments TTM EBITDA year-on-year change?
Over the past year, CLOV TTM EBITDA has changed by +$67.85 M (+42.24%)